1h Free Analyst Time
The bone grafts and substitutes market is forecast to grow by USD 1.71 billion during 2023-2028, accelerating at a CAGR of 9.45% during the forecast period. The report on the bone grafts and substitutes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing orthopedic conditions and surgical cases, increasing demand for dental bone grafts, and rising investment in clinical trials.
The bone grafts and substitutes market is segmented as below:
By Product
- Xenografts
- Allografts
- Synthetic bone grafts
- DBM
By Application
- Spinal fusion
- Trauma
- Craniomaxillofacial
- Joint reconstruction
- Dental bone grafting
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the bone grafts and substitutes market covers the following areas:
- Bone grafts and substitutes market sizing
- Bone grafts and substitutes market forecast
- Bone grafts and substitutes market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global bone grafts and substitutes market: AlloSource, Arthrex Inc., Baxter International Inc., Bioventus LLC, Ed. Geistlich Sohne AG, Institut Straumann AG, Integra Lifesciences Corp., Johnson and Johnson Services Inc., Medtronic Plc, MTF Biologics, NovaBone Products LLC, Nuvasive Inc., Orthofix Medical Inc., OST Laboratories, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., TBF TISSUE ENGINEERING, Xtant Medical Holdings Inc., and Zimmer Biomet Holdings Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing adoption of minimally invasive surgeries."
According to the report, one of the major drivers for this market is the growing orthopedic conditions and surgical cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AlloSource
- Arthrex Inc.
- Baxter International Inc.
- Bioventus LLC
- Ed. Geistlich Sohne AG
- Institut Straumann AG
- Integra Lifesciences Corp.
- Johnson and Johnson Services Inc.
- Medtronic Plc
- MTF Biologics
- NovaBone Products LLC
- Nuvasive Inc.
- Orthofix Medical Inc.
- OST Laboratories
- RTI Surgical Inc.
- Smith and Nephew plc
- Stryker Corp.
- TBF TISSUE ENGINEERING
- Xtant Medical Holdings Inc.
- Zimmer Biomet Holdings Inc.
